The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study
- Resource Type
- Article
- Source
- In
ESMO Open February 2024 9(2) - Subject
Phase I Trials - Language
- ISSN
- 2059-7029